Oxford Biomedica (LON:OXB) Shares Cross Above 50-Day Moving Average – Here’s What Happened

Shares of Oxford Biomedica plc (LON:OXBGet Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 420.59 ($5.29) and traded as high as GBX 426 ($5.36). Oxford Biomedica shares last traded at GBX 421.50 ($5.30), with a volume of 43,576 shares trading hands.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft raised their target price on shares of Oxford Biomedica from GBX 250 ($3.15) to GBX 380 ($4.78) and gave the stock a “hold” rating in a report on Tuesday, September 24th.

View Our Latest Stock Analysis on OXB

Oxford Biomedica Stock Performance

The company has a debt-to-equity ratio of 154.88, a current ratio of 2.35 and a quick ratio of 1.67. The firm has a market capitalization of £444.09 million, a PE ratio of -292.71 and a beta of 1.09. The firm has a fifty day moving average price of GBX 420.59 and a 200 day moving average price of GBX 371.66.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Recommended Stories

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.